2023 International Health Cooperation Conference (IHCC) - Changzhou First People's Hospital Special Session

• by EVOMT
• 2023-07-02

On May 31st, the 2023 International Health Cooperation Conference (IHCC) - Changzhou First People's Hospital Academic Special Session was successfully held. David, Director of the International Medical Department and Cooperation Department of EVO Medical, and Vice President of Dana Faber Oncology Hospital affiliated with Harvard Medical School in the United States C Read and his delegation visited Changzhou First People's Hospital. Professor Hua Fei, Secretary of the Party Committee of the Academy, Professor Xing Wei, Vice President of the Academy, Professor Wu Jun, Director of the Department of Oncology, Professor Gu Wendong, Director of the Department of Radiotherapy for Oncology, Professor Ding Jiule, Deputy Director of the Science and Technology Department, Professor Wang Mengjie, Assistant Director of the Party and Government General Office (Office of Foreign Cooperation and Exchange) and other officials attended the exchange.

Professor Hua Fei, Secretary of the Party Committee, introduced that Changzhou First People's Hospital is the largest tertiary and first-class comprehensive hospital in Changzhou, Jiangsu Province. The hospital covers an area of nearly 75000 square meters, with an annual diagnosis and treatment of 3.3395 million people, and 67353 surgeries and procedures. The hospital has 45 clinical departments, 7 medical technology departments, 2 research institutions, and 1 health management center. I hope that through friendly exchanges between both parties, we can promote the establishment of a friendly cooperative partnership between Changzhou First People's Hospital and Dana Faber Cancer Hospital, especially in the field of clinical diagnosis and research in the field of cancer treatment, with complementary advantages, and jointly promote the development of human health.

Professor David C. Read introduced Dana Farber Cancer Institute, which is the Harvard Medical School School), which is also a comprehensive cancer treatment center designated by the Federal government of the United States of the United States. It is the leader in cancer treatment in the United States Center) has close cooperation and has obtained 26 certifications from the Food and Drug Administration (FDA). Professor Read expressed his pleasure to visit Changzhou First People's Hospital on site and expressed sincere appreciation for the development process of Changzhou First People's Hospital. He hoped that in the future, both sides could have in-depth exchanges and achieve multiple cooperation between hospitals in medical, education, scientific research, and management.

Professor Wu Jun, Director of the Oncology Department, introduced the situation of the Oncology Department. The Oncology Therapy Department of Changzhou First Hospital has been designated as a key medical discipline in Jiangsu Province. The Oncology Therapy Department has become a modern regional cancer diagnosis and treatment center that integrates medical education, research, prevention and management, and features tumor biological therapy. The development scale and academic status of the discipline are firmly among the top in Jiangsu Province's oncology specialties.

Professor Gu Wendong, Director of the Cancer Radiotherapy Department, introduced the situation of the Cancer Radiology Department. Changzhou First Hospital has the world's top linear accelerator that can perform one click non coplanar radiation surgery technology, HyperArc. Through real-time automatic tracking and accurate capture of tumor localization, precise guidance with submillimeter precision can achieve high-quality, efficient, and non-invasive radiation surgery treatment; Equipped with the world's advanced AXESSES linear accelerator, we carry out precise irradiation technologies such as Volume Intensity Modulation (VMAT), four-dimensional CT image guided stereotactic radiotherapy, Sentinel monitoring and assisted positioning.

Subsequently, both parties held discussions and exchanges to promote the high-level international construction of Changzhou First Institute through exchanges and cooperation with top universities and international scholars. In the future, the participating parties will hold a series of exchange meetings to continuously promote deep cooperation in relevant aspects, and look forward to achieving fruitful research results through the efforts of both parties. The attending parties believe that this exchange will deepen their understanding and further determine the cooperation content. They look forward to the holding of the seminar and the development of mutual visits, exchanges, and learning.